Amalya Sargsyan: Fantastic paper out in AACR Journals on the role of TME in NSCLC
Amalya Sargsyan, Medical Oncologist at Yeolyan Oncology and Hematology Center, shared on LinkedIn:
“Is targeting the tumor microenvironment the key to unlocking the next generation of cancer therapies?
Following the presentation at AACR2024 by Charles Swanton, this fantastic paper was out in AACR Journals on the role of TME in NSCLC.
4 TME classes in NSCLC, including a class marked by high neutrophil infiltration.
Links between TME architecture, neoantigen burden, and immune evasion spotlight the complexity of cancer evolution.
The study emphasizes the potential of targeted therapies focusing on specific TME characteristics for better outcomes.
TRACERx initiative by Cancer Research UK and The Francis Crick Institute.”
Proceed to the article.
Source: Amalya Sargsyan/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023